{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:09:36Z","timestamp":1787731776863,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["19EIA34760167"],"award-info":[{"award-number":["19EIA34760167"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL130301-01"],"award-info":[{"award-number":["1R01HL130301-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL147639-01A1"],"award-info":[{"award-number":["1R01HL147639-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL155265-01"],"award-info":[{"award-number":["1R01HL155265-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["2020AHA000POST000204982"],"award-info":[{"award-number":["2020AHA000POST000204982"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["APS APHYS00010"],"award-info":[{"award-number":["APS APHYS00010"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005384","name":"American Physiological Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005384","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vph.2022.107093","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T08:23:53Z","timestamp":1659169433000},"page":"107093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice"],"prefix":"10.1016","volume":"146","author":[{"given":"Reem T.","family":"Atawia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleton R.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Kennard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Belin de Chantem\u00e8le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vph.2022.107093_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.2014.6228","article-title":"Prevalence of obesity in the United States","volume":"312","author":"Ogden","year":"2014","journal-title":"Jama"},{"issue":"23","key":"10.1016\/j.vph.2022.107093_bb0010","doi-asserted-by":"crossref","first-page":"17271","DOI":"10.1074\/jbc.R110.113175","article-title":"Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins","volume":"285","author":"Hall","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.vph.2022.107093_bb0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrendo.2014.44","article-title":"The pathophysiology of hypertension in patients with obesity","volume":"10","author":"DeMarco","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.vph.2022.107093_bb0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/HYPERTENSIONAHA.109.148213","article-title":"Positive relationship between plasma leptin level and hypertension","volume":"56","author":"Shankar","year":"2010","journal-title":"Hypertension"},{"issue":"6704","key":"10.1016\/j.vph.2022.107093_bb0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vph.2022.107093_bb0030","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","article-title":"Leptin levels in human and rodent: measurement of plasma leptin and Ob RNA in obese and weight-reduced subjects","volume":"1","author":"Maffei","year":"1995","journal-title":"Nat. Med."},{"issue":"S3","key":"10.1016\/j.vph.2022.107093_bb0035","doi-asserted-by":"crossref","first-page":"103S","DOI":"10.1016\/S0895-7061(01)02077-5","article-title":"Obesity hypertension: role of leptin and sympathetic nervous system","volume":"14","author":"Hall","year":"2001","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.vph.2022.107093_bb0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.HYP.31.1.409","article-title":"Chronic leptin infusion increases arterial pressure","volume":"31","author":"Shek","year":"1998","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.vph.2022.107093_bb0045","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/diabetes.54.7.2012","article-title":"Role of selective leptin resistance in diet-induced obesity hypertension","volume":"54","author":"Rahmouni","year":"2005","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.vph.2022.107093_bb0050","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI8341","article-title":"Pathophysiological role of leptin in obesity-related hypertension","volume":"105","author":"Aizawa-Abe","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.vph.2022.107093_bb0055","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/nu11092129","article-title":"Functional relationship between leptin and nitric oxide in metabolism","volume":"11","author":"Becerril","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.vph.2022.107093_bb0060","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/HYPERTENSIONAHA.119.13398","article-title":"Leptin restores endothelial function via endothelial PPAR\u03b3-Nox1\u2013mediated mechanisms in a mouse model of congenital generalized lipodystrophy","volume":"74","author":"Bruder-Nascimento","year":"2019","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.vph.2022.107093_bb0065","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.HYP.37.2.670","article-title":"Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin","volume":"37","author":"Kuo","year":"2001","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.vph.2022.107093_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1440-1681.2011.05623.x","article-title":"Leptin and the regulation of endothelial function in physiological and pathological conditions","volume":"39","author":"Be\u0142towski","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"4","key":"10.1016\/j.vph.2022.107093_bb0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2337\/diabetes.48.4.903","article-title":"Pivotal role of nitric oxide in the control of blood pressure after leptin administration","volume":"48","author":"Fr\u00fchbeck","year":"1999","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.vph.2022.107093_bb0080","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/hy1101.096053","article-title":"Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation?","volume":"38","author":"Mitchell","year":"2001","journal-title":"Hypertension"},{"issue":"2\u20133","key":"10.1016\/j.vph.2022.107093_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2005.06.015","article-title":"Lack of dilator effect of leptin in the hindlimb vascular bed of conscious rats","volume":"518","author":"Rahmouni","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"19","key":"10.1016\/j.vph.2022.107093_bb0090","doi-asserted-by":"crossref","first-page":"10596","DOI":"10.3390\/ijms221910596","article-title":"Reduced endothelial leptin signaling increases vascular adrenergic reactivity in a mouse model of congenital generalized lipodystrophy","volume":"22","author":"Bruder-Nascimento","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2022.107093_bb0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/diabetes.51.1.168","article-title":"Leptin effect on endothelial nitric oxide is mediated through Akt\u2013endothelial nitric oxide synthase phosphorylation pathway","volume":"51","author":"Vecchione","year":"2002","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.vph.2022.107093_bb0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/HYPERTENSIONAHA.110.168427","article-title":"Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice","volume":"58","author":"Belin de Chantem\u00e8le","year":"2011","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.vph.2022.107093_bb0105","doi-asserted-by":"crossref","first-page":"10977","DOI":"10.3390\/ijms222010977","article-title":"Chronic exposure to HIV-derived protein tat impairs endothelial function via indirect alteration in fat mass and nox1-mediated mechanisms in mice","volume":"22","author":"Kovacs","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.vph.2022.107093_bb0110","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1096\/fasebj.13.10.1231","article-title":"Leptin induces oxidative stress in human endothelial cells","volume":"13","author":"Bouloumi\u00e9","year":"1999","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.vph.2022.107093_bb0115","first-page":"H48","article-title":"Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction","volume":"289","author":"Knudson","year":"2005","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"5","key":"10.1016\/j.vph.2022.107093_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000299","article-title":"Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity","volume":"2","author":"Wang","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2022.107093_bb0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.phrs.2015.10.012","article-title":"Deletion of protein tyrosine phosphatase 1b in proopiomelanocortin neurons reduces neurogenic control of blood pressure and protects mice from leptin-and sympatho-mediated hypertension","volume":"102","author":"Bruder-Nascimento","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.vph.2022.107093_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1677\/JOE-09-0079","article-title":"A new mouse model of metabolic syndrome and associated complications","volume":"202","author":"Wang","year":"2009","journal-title":"J. Endocrinol."},{"issue":"9","key":"10.1016\/j.vph.2022.107093_bb0135","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.109.853077","article-title":"Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function","volume":"120","author":"Belin de Chantem\u00e8le","year":"2009","journal-title":"Circulation"},{"issue":"6772","key":"10.1016\/j.vph.2022.107093_bb0140","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/35002663","article-title":"Leptin and diabetes in lipoatrophic mice","volume":"403","author":"Gavrilova","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vph.2022.107093_bb0145","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1164\/ajrccm.159.5.9809025","article-title":"Leptin prevents respiratory depression in obesity","volume":"159","author":"O\u2019donnell","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.vph.2022.107093_bb0150","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/HYPERTENSIONAHA.112.196295","article-title":"Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity","volume":"60","author":"De Chantem\u00e8le","year":"2012","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.vph.2022.107093_bb0155","first-page":"R1438","article-title":"Shp2 signaling in POMC neurons is important for leptin\u2019s actions on blood pressure, energy balance, and glucose regulation","volume":"307","author":"Do Carmo","year":"2014","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"34","key":"10.1016\/j.vph.2022.107093_bb0160","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.1523\/JNEUROSCI.2336-11.2011","article-title":"Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance","volume":"31","author":"Enriori","year":"2011","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.vph.2022.107093_bb0165","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/ATVBAHA.110.210070","article-title":"Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-\u0152\u2264 pathway","volume":"30","author":"Payne","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.vph.2022.107093_bb0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2337\/diabetes.49.2.293","article-title":"Leptin induces direct vasodilation through distinct endothelial mechanisms","volume":"49","author":"Lembo","year":"2000","journal-title":"Diabetes"},{"issue":"19","key":"10.1016\/j.vph.2022.107093_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018074","article-title":"HIV protease inhibitor ritonavir impairs endothelial function via reduction in adipose mass and endothelial leptin receptor-dependent increases in NADPH oxidase 1 (Nox1), C-C chemokine receptor type 5 (CCR5), and inflammation","volume":"9","author":"Bruder-Nascimento","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.vph.2022.107093_bb0180","first-page":"1474","article-title":"Low nitric oxide bioavailability increases renin production in the collecting duct","author":"Curnow","year":"2020","journal-title":"Front. Physiol."},{"issue":"12","key":"10.1016\/j.vph.2022.107093_bb0185","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1681\/ASN.2013091030","article-title":"Renal angiotensin-converting enzyme is essential for the hypertension induced by nitric oxide synthesis inhibition","volume":"25","author":"Giani","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.vph.2022.107093_bb0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1590\/S0100-879X2006005000077","article-title":"Sympathetic activation in rats with L-NAME-induced hypertension","volume":"40","author":"Biancardi","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"2","key":"10.1016\/j.vph.2022.107093_bb0195","first-page":"R367","article-title":"Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system","volume":"274","author":"Scrogin","year":"1998","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"8","key":"10.1016\/j.vph.2022.107093_bb0200","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1681\/ASN.V1281706","article-title":"Angiotensin II and prostaglandin interactions on systemic and renal effects of L-NAME in humans","volume":"12","author":"Perinotto","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.vph.2022.107093_bb0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.hjh.0000194116.89356.66","article-title":"Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism","volume":"24","author":"Colonna","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2022.107093_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117047","article-title":"PPAR-\u03b3 agonist, pioglitazone, reduced oxidative and endoplasmic reticulum stress associated with L-NAME-induced hypertension in rats","volume":"239","author":"Soliman","year":"2019","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.vph.2022.107093_bb0215","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/bph.12960","article-title":"Cardiac NO signalling in the metabolic syndrome","volume":"172","author":"Pechanova","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.vph.2022.107093_bb0220","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2337\/diabetes.47.10.1555","article-title":"Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans","volume":"47","author":"Weyer","year":"1998","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.vph.2022.107093_bb0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1476-5381.1992.tb14270.x","article-title":"Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery","volume":"105","author":"Garland","year":"1992","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2022.107093_bb0230","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00004872-200106000-00014","article-title":"Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects","volume":"19","author":"Narkiewicz","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2022.107093_bb0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fphys.2017.00032","article-title":"Long term high fat diet treatment: an appropriate approach to study the sex-specificity of the autonomic and cardiovascular responses to obesity in mice","volume":"8","author":"Bruder-Nascimento","year":"2017","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.vph.2022.107093_bb0240","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/HYPERTENSIONAHA.115.06981","article-title":"Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis","volume":"67","author":"Salles","year":"2016","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.vph.2022.107093_bb0245","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/jhh.2009.9","article-title":"Night\u2013day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension","volume":"23","author":"Fagard","year":"2009","journal-title":"J. Hum. Hypertens."},{"issue":"9","key":"10.1016\/j.vph.2022.107093_bb0250","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archinternmed.2009.68","article-title":"Prognostic value of nocturnal blood pressure reduction in resistant hypertension","volume":"169","author":"Muxfeldt","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.vph.2022.107093_bb0255","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10641960802251974","article-title":"Causes and mechanisms of nondipping hypertension","volume":"30","author":"Kanbay","year":"2008","journal-title":"Clin. Exp. Hypertens."},{"issue":"5","key":"10.1016\/j.vph.2022.107093_bb0260","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1464-5491.2000.00284.x","article-title":"Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus","volume":"17","author":"Sturrock","year":"2000","journal-title":"Diabet. Med."},{"issue":"4","key":"10.1016\/j.vph.2022.107093_bb0265","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.HYP.0000158261.86674.8e","article-title":"Impact of obesity on 24-hour ambulatory blood pressure and hypertension","volume":"45","author":"Kotsis","year":"2005","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.vph.2022.107093_bb0270","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/HYPERTENSIONAHA.115.06642","article-title":"Leptin induces hypertension and endothelial dysfunction via aldosterone-dependent mechanisms in obese female mice","volume":"67","author":"Huby","year":"2016","journal-title":"Hypertension"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:22:41Z","timestamp":1761528161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189122001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":54,"alternative-id":["S1537189122001422"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2022.107093","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2022.107093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107093"}}